Canakinumab Subcutaneous and Glipizide Extended-Release Tablets
Determining the interaction of Canakinumab Subcutaneous and Glipizide Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: glipizide
Brand name: Glucotrol, Glucotrol XL, Glipizide XL
Synonyms: Glipizide, GlipiZIDE
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Glipizide Tablets
- Canakinumab Subcutaneous-Glipizide XL
- Canakinumab Subcutaneous-Glofil-125
- Canakinumab Subcutaneous-Gloperba
- Canakinumab Subcutaneous-GloStrips
- Canakinumab Subcutaneous-Glucagen
- Glipizide Extended-Release Tablets-Canasa
- Glipizide Extended-Release Tablets-Canasa Pac rectal
- Glipizide Extended-Release Tablets-Canasa rectal
- Glipizide Extended-Release Tablets-Cancidas
- Glipizide Extended-Release Tablets-Candesartan
- Glipizide Extended-Release Tablets-Candesartan and Hydrochlorothiazide